Healome Therapeutics
PrivateLast Round
Seed
Jul 7, 2026
Total Funding Raised
$3.03M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Healome Therapeutics is a United Kingdom-based ophthalmology company developing a platform eye-drop matrix technology for ocular surface diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Healome Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Healome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 7, 2026 | ||||
| Pre Seed | Apr 27, 2022 |
Key People
Founding team and executive leadership
Healome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oshen Holdings SA | Seed |
| Empirical Ventures | Seed |
| Innovate UK | Pre Seed |
| SFC Capital | Pre Seed, Seed |
| DEBRA Research gGmbH | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2026
$2.68M round led by Empirical Ventures.
- Apr 27, 2022
$532K round with SFC Capital and Innovate UK
Healome Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Healome Therapeutics's valuation, stock price, and market status.